Anthracyclines for gestational breast cancer: course and outcome of pregnancy.
Department of Medicine, European Institute of Oncology.
H A
HA
Azim
Department of Medicine, European Institute of Oncology. Electronic address: fedro.peccatori@ieo.it.
F A
FA
Peccatori
Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.
G
G
Scarfone
Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.
B
B
Acaia
Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.
P
P
Rossi
Department of Medicine, European Institute of Oncology.
R
R
Cascio
Department of Medicine, European Institute of Oncology.
A
A
Goldhirsch
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome
D015251:Epirubicin; D004317:Doxorubicin